# Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

Study · id `cardio:ct-nct03399994` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03399994](<https://clinicaltrials.gov/study/NCT03399994>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03399994

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 137 participants.

## Technical summary

Registry record NCT03399994. Randomized; single masking; primary purpose treatment. Start 2018-05-21 (actual); primary completion 2021-04-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 137 participants (enrolled count; ClinicalTrials.gov record NCT03399994, source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)
- Started: 2018-05-21 (actual) (ClinicalTrials.gov record NCT03399994, source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)
- Primary completion: 2021-04-15 (actual) (ClinicalTrials.gov record NCT03399994, source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)
- Completion: 2022-07-26 (actual) (ClinicalTrials.gov record NCT03399994, source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT03399994, source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03399994-2022-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
- Condition: Coronary Artery Disease
- Condition: Diabetes
- Intervention (Device): device implantation during coronary angioplasty
- Lead sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
- Lead sponsor class: OTHER
- Collaborator: Mediolanum Cardio Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS (`cardio:org-fondazione-evidence-per-attivita-e-ricerche-cardiovascolari-aa9be1`)
- Registry lists this organization as a collaborator: Mediolanum Cardio Research (`cardio:org-mediolanum-cardio-research`)

## Provenance

Content hash: d7607b93bfb24448a34d734cc424597a78e4ba193bbb8d32dfc08be152baba15
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
